ATE226089T1 - Verwendung einer zubereitung enthaltend einen plasminogen-aktivator für die verbesserung der wundheilung - Google Patents

Verwendung einer zubereitung enthaltend einen plasminogen-aktivator für die verbesserung der wundheilung

Info

Publication number
ATE226089T1
ATE226089T1 AT95200208T AT95200208T ATE226089T1 AT E226089 T1 ATE226089 T1 AT E226089T1 AT 95200208 T AT95200208 T AT 95200208T AT 95200208 T AT95200208 T AT 95200208T AT E226089 T1 ATE226089 T1 AT E226089T1
Authority
AT
Austria
Prior art keywords
plasminogen activator
wound healing
preparation containing
improving wound
present
Prior art date
Application number
AT95200208T
Other languages
English (en)
Inventor
Johan Hendrikus Verheijen
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Application granted granted Critical
Publication of ATE226089T1 publication Critical patent/ATE226089T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
AT95200208T 1995-01-27 1995-01-27 Verwendung einer zubereitung enthaltend einen plasminogen-aktivator für die verbesserung der wundheilung ATE226089T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95200208A EP0723782B1 (de) 1995-01-27 1995-01-27 Verwendung einer Zubereitung enthaltend einen Plasminogen-Aktivator für die Verbesserung der Wundheilung

Publications (1)

Publication Number Publication Date
ATE226089T1 true ATE226089T1 (de) 2002-11-15

Family

ID=8219975

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95200208T ATE226089T1 (de) 1995-01-27 1995-01-27 Verwendung einer zubereitung enthaltend einen plasminogen-aktivator für die verbesserung der wundheilung

Country Status (5)

Country Link
US (2) US5925350A (de)
EP (1) EP0723782B1 (de)
JP (1) JP3980088B2 (de)
AT (1) ATE226089T1 (de)
DE (1) DE69528573T2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8092834B2 (en) * 2001-06-29 2012-01-10 Shiseido Co., Ltd. Composite powders and skin preparations for external use containing the same
US7067492B2 (en) 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
US7202066B2 (en) * 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme
AU2003281462A1 (en) * 2002-07-19 2004-02-09 Santen Pharmaceutical Co., Ltd. Corneal epithelium injury-healing accelerator
WO2005040194A2 (en) * 2003-10-24 2005-05-06 Ludwig Institute For Cancer Research Methods and compositions for pdgf-c activation and inhibition
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
WO2014006613A2 (en) * 2012-07-05 2014-01-09 Hadasit Medical Research Services & Development Limited Plasminogen activator mutants as anti-fibrinolytic agents
ES2523458B1 (es) * 2013-05-23 2015-07-15 José Manuel GALEANO SALVADOR Composición farmacéutica o cosmética para la regeneración y cicatrización de la piel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0227400B1 (de) * 1985-12-16 1991-12-04 Ethicon, Inc. Hemmung von post-chirurgischer Adhäsionsbildung durch topische Verabreichung von Gewebeplasminogenaktivator
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
US5364622A (en) * 1987-12-04 1994-11-15 Dr. Karl Thomae Gmbh Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
DE4411143C2 (de) * 1994-03-30 1996-08-01 Immuno Ag Thrombosemittel

Also Published As

Publication number Publication date
EP0723782A1 (de) 1996-07-31
EP0723782B1 (de) 2002-10-16
DE69528573D1 (de) 2002-11-21
US6033664A (en) 2000-03-07
JPH08253425A (ja) 1996-10-01
US5925350A (en) 1999-07-20
JP3980088B2 (ja) 2007-09-19
DE69528573T2 (de) 2003-06-18

Similar Documents

Publication Publication Date Title
ATE512650T1 (de) Hydrogelwundverband und zugehöriges herstellungs- und benutzungsverfahren
ATE196604T1 (de) Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und - regenerierung
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
DE69734661D1 (de) Foerderung der wundheilung durch chemisch modifizierte tetracycline
ATE221358T1 (de) Verbandssystem
ATE290397T1 (de) Formulierung fur die wundheilung mit menschlichem plasma fibronektin
AU5094985A (en) Wound healing agents
DE59911740D1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
DE69627680D1 (de) Verwendung von kohlehydraten zur foerderung der schuppenden haut
DE69528573D1 (de) Verwendung einer Zubereitung enthaltend einen Plasminogen-Aktivator für die Verbesserung der Wundheilung
ATE267578T1 (de) Verwendung mindestens eines hydroxystilben in einer zusammensetzung, die die abschuppung der haut fördern soll.
ATE192924T1 (de) Liposomal verkapseltes taxol, seine herstellung und seine verwendung
EP2063832A4 (de) Fester verband zur behandlung von wundgewebe
ATE306921T1 (de) Verwendung von cs-866 (olmersartan) zur herstellung eines medikaments für die behandlung von arteriosklerose
DE3781182D1 (de) Tamoxifen zur topischen verwendung.
DE69330727D1 (de) Gefriergetrockneter Verband
ATE223228T1 (de) Verwendung von latenz assoziierten peptiden in der herstellung eines medikaments zur verbesserung der wundheilung.
ATE236638T1 (de) Neue verwendung von prostaglandinen
ATE141794T1 (de) Stimulierung von wundheilung mit 15-keto- prostaglandinverbindungen
ATE410195T1 (de) Hydrokolloidzusammensetzungen
DE68905342D1 (de) Verwendung von minoxidil zur wundheilung.
ES540447A0 (es) Un metodo de preparar un vendaje
GB2347625A (en) Agent for treating allergic or hypersensivity condition
ATE245443T1 (de) Verfahren zur herstellung von konzentrierten lösungen von fibronectin ohne puffer
AU589283B2 (en) Synergistic blood clot treatment composition comprising tissue plasminogen activator and a prostaglandin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0723782

Country of ref document: EP

REN Ceased due to non-payment of the annual fee